HP
Hendrik Peter Scholl sold $83K of BLTE stock
Hendrik Peter Scholl, Chief Medical Officer of Belite Bio, Inc (BLTE), sold 500 shares of BLTE stock worth $83K, per an SEC Form 4 filed Oct 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 1, 2026, 4 days before it was made public.
BLTE has moved -21.8% since the trade date, from $162.98 to $127.38 (Nov 20, 2026 close).
- Traded
- Oct 1, 2026
- Disclosed
- Oct 5, 2026
- Filing delay
- 4 days
- Price since
- -21.8%
- Role
- Chief Medical Officer
- Source
- SEC Form 4